These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29305821)

  • 41. Cost-effectiveness and Budget Impact of Routine Use of Fractional Exhaled Nitric Oxide Monitoring for the Management of Adult Asthma Patients in Spain.
    Sabatelli L; Seppälä U; Sastre J; Crater G
    J Investig Allergol Clin Immunol; 2017; 27(2):89-97. PubMed ID: 27564130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Budget impact analysis of a novel gene expression assay for the diagnosis of malignant melanoma.
    Cassarino DS; Lewine N; Cole D; Wade B; Gustavsen G
    J Med Econ; 2014 Nov; 17(11):782-91. PubMed ID: 25170544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention versus early detection for long-term control of melanoma and keratinocyte carcinomas: a cost-effectiveness modelling study.
    Gordon L; Olsen C; Whiteman DC; Elliott TM; Janda M; Green A
    BMJ Open; 2020 Feb; 10(2):e034388. PubMed ID: 32107270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.
    Moloney FJ; Guitera P; Coates E; Haass NK; Ho K; Khoury R; O'Connell RL; Raudonikis L; Schmid H; Mann GJ; Menzies SW
    JAMA Dermatol; 2014 Aug; 150(8):819-27. PubMed ID: 24964862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
    Khan MM; Sharma S; Tripathi B; Alvarez FP
    Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Budesonide + formoterol delivered via Spiromax
    Lewis A; Torvinen S; Dekhuijzen PNR; Chrystyn H; Melani A; Zöllner Y; Kolbe K; Watson AT; Blackney M; Plich A
    Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment.
    King AB; Saag KG; Burge RT; Pisu M; Goel N
    Osteoporos Int; 2005 Dec; 16(12):1545-57. PubMed ID: 15942702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Budget impact analysis of gene expression tests to aid therapy decisions for breast cancer patients in Germany.
    Lux MP; Nabieva N; Hildebrandt T; Rebscher H; Kümmel S; Blohmer JU; Schrauder MG
    Breast; 2018 Feb; 37():89-98. PubMed ID: 29128582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis.
    Maxwell S; Brameld K; Youngs L; Geelhoed E; O'Leary P
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):51-9. PubMed ID: 20218998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost comparison between ultrasound-guided 14-g large core breast biopsy and open surgical biopsy: an analysis for Austria.
    Gruber R; Walter E; Helbich TH
    Eur J Radiol; 2010 Jun; 74(3):519-24. PubMed ID: 19427153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melanoma screening: A plan for improving early detection.
    Shellenberger R; Nabhan M; Kakaraparthi S
    Ann Med; 2016; 48(3):142-8. PubMed ID: 26911192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis.
    Gordon LG; Hyland CA; Hyett JA; O'Brien H; Millard G; Flower RL; Gardener GJ
    Prenat Diagn; 2017 Dec; 37(12):1245-1253. PubMed ID: 29096422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating the economic costs of skin cancer in New South Wales, Australia.
    Doran CM; Ling R; Byrnes J; Crane M; Searles A; Perez D; Shakeshaft A
    BMC Public Health; 2015 Sep; 15():952. PubMed ID: 26400024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness of asthma clinic approach in the management of chronic asthma in Australia.
    Mogasale V; Vos T
    Aust N Z J Public Health; 2013 Jun; 37(3):205-10. PubMed ID: 23731101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia.
    Lindsay D; Bell KJL; Olsen CM; Whiteman DC; Pathirana T; Collins LG
    Br J Dermatol; 2024 Jul; ():. PubMed ID: 39026390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy.
    Tromme I; Legrand C; Devleesschauwer B; Leiter U; Suciu S; Eggermont A; Sacré L; Baurain JF; Thomas L; Beutels P; Speybroeck N
    Eur J Cancer; 2016 Nov; 67():38-45. PubMed ID: 27592070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Budget Impact of Increased Use of Febuxostat in the Management of Gout: A US Health Plan Managed Care Pharmacy and Medical Costs Perspective.
    Smolen LJ; Gahn JC; Mitri G; Shiozawa A
    Clin Ther; 2016 Jul; 38(7):1710-25. PubMed ID: 27269247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modelling the resource implications and budget impact of managing cow milk allergy in Australia.
    Guest JF; Nagy E
    Curr Med Res Opin; 2009 Feb; 25(2):339-49. PubMed ID: 19192978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.
    Merlo G; Graves N; Brain D; Connelly LB
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1927-1932. PubMed ID: 27043242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.